Data gathered: May 17
Alternative Data for Cytek BioSciences
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 15 | Sign up | Sign up | Sign up | |
Sentiment | 83 | Sign up | Sign up | Sign up | |
Webpage traffic | 28,000 | Sign up | Sign up | Sign up | |
Employee Rating | 72 | Sign up | Sign up | Sign up | |
Google Trends | 4 | Sign up | Sign up | Sign up | |
Patents | 24 | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 15 | Sign up | Sign up | Sign up | |
Facebook Followers | 732 | Sign up | Sign up | Sign up | |
Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 86 | Sign up | Sign up | Sign up | |
Twitter Followers | 1,139 | Sign up | Sign up | Sign up | |
Twitter Mentions | 8 | Sign up | Sign up | Sign up | |
Youtube Subscribers | 1,380 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | N/A | Sign up | Sign up | Sign up | |
Business Outlook | 80 | Sign up | Sign up | Sign up | |
Linkedin Employees | 389 | Sign up | Sign up | Sign up |
About Cytek BioSciences
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
Price | $6.18 |
Target Price | Sign up |
Volume | 513,870 |
Market Cap | $827M |
Year Range | $4.1 - $9.51 |
Dividend Yield | 0% |
PE Ratio | 351.5 |
Revenue per Employee | $361,777 |
Industry | Medical Devices |
In the news
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytek Biosciences (CTKB), Elanco Animal Health (ELAN) and Atara Biotherapeutics (ATRA)May 13 - TipRanks |
|
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call TranscriptMay 13 - Yahoo Entertainment |
|
Piper Sandler Cuts Cytek Biosciences (NASDAQ:CTKB) Price Target to $8.50May 13 - ETF Daily News |
|
Cytek Biosciences (CTKB) Gets a Buy from Piper SandlerMay 12 - TipRanks |
|
Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call TranscriptMay 11 - SeekingAlpha |
|
Cytek Biosciences Inc (CTKB) Q1 2024 Earnings: Revenue Surges, Yet Net Loss PersistsMay 10 - Yahoo Entertainment |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q1 '24 | 45M | 22M | 23M | -6.2M | -7.7M | -0.050 |
Q4 '23 | 58M | 25M | 33M | 5.5M | 5.4M | 0.040 |
Q3 '23 | 48M | 21M | 27M | -6.5M | -2.7M | -0.050 |
Q2 '23 | 50M | 22M | 28M | -4.4M | -5.2M | -0.030 |
Q1 '23 | 37M | 16M | 21M | -6.8M | -7.9M | -0.050 |
Insider Transactions View All
Yan Ming filed to sell 5,988,502 shares at $5.9. April 23 '24 |
Yan Ming filed to sell 6,008,502 shares at $7. April 11 '24 |
Yan Ming filed to sell 6,008,902 shares at $7. April 11 '24 |
Yan Ming filed to sell 6,010,402 shares at $6.7. March 19 '24 |
Jeanmonod Patrik filed to sell 93,400 shares at $9.5. December 27 '23 |
Similar companies
Company | Price | AI Score | |
---|---|---|---|
Boston ScientificBSX |
$74.55 0% | 64 |
|
Edwards LifesciencesEW |
$90.11 0% | 58 |
|
Intuitive SurgicalISRG |
$396.43 0% | 59 |
|
MedtronicMDT |
$85.64 0% | 56 |
|
StrykerSYK |
$334.1 0% | 59 |
Read more about Cytek BioSciences (CTKB) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Cytek BioSciences?
The Market Cap of Cytek BioSciences is $827M.
What is Cytek BioSciences' PE Ratio?
As of today, Cytek BioSciences' PE (Price to Earnings) ratio is 351.5.
How Many People Work at Cytek BioSciences?
As of our latest update, Cytek BioSciences employed approximately 555 people worldwide. However, it's important to note that Cytek BioSciences' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Cytek BioSciences' revenue per employee?
$361,777. To calculate Cytek BioSciences' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Cytek BioSciences?
Currently, the price of one share of Cytek BioSciences stock is $6.18.
How can I analyze the CTKB stock price chart for investment decisions?
The CTKB stock price chart above provides a comprehensive visual representation of Cytek BioSciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cytek BioSciences shares. Our platform offers an up-to-date CTKB stock price chart, along with technical data analysis and alternative data insights.
Does CTKB offer dividends to its shareholders?
As of our latest update, Cytek BioSciences (CTKB) does not offer dividends to its shareholders. Investors interested in Cytek BioSciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Cytek BioSciences?
Some of the similar stocks of Cytek BioSciences are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.